Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Long-Term Projected Growth Rate for the Zoonotic Disease Treatment Market, and What Are the Key Drivers?
The market size for treating zoonotic diseases has seen a significant uptick in recent years. It’s set to rise from $39.71 billion in 2024 to $42.64 billion in 2025, representing a compound annual growth rate (CAGR) of 7.4%. Factors contributing to the growth during the historic period include the occurrence of substantial zoonotic outbreaks, expansion of urban areas, habitat encroachment, the adoption of a unified health approach, heightened surveillance and reporting, globalization, augmented travel, and a rise in public awareness and education.
The market size for treating zoonotic diseases is projected to expand significantly in the coming years. By 2029, the market is estimated to be worth $55.92 billion, reflecting a compound annual growth rate (CAGR) of 7.0%. The predicted growth during the forecast period is largely due to factors such as climate and environmental changes, fund allocation by governments and international organizations, advancements in medical devices, supportive regulatory measures and efficient approvals, as well as joint research and development efforts. Key trends anticipated during the forecast period are the creation of broad-range antiviral treatments, reinforcement of the global health facilities, advancements in diagnosis technologies, expansion in the developments of vaccines, and an emphasis on preventive actions.
What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Zoonotic Disease Treatment Market?
The surge in the need for animal proteins is poised to boost the zoonotic disease treatment market’s expansion going forward. Originating from sources like meat, dairy, eggs, and fish, animal proteins encompass all vital amino acids essential for human health. Various factors, including the swelling global populace, improved income levels, urbanization, and an increase in cognizance about the nutritional gains of animal-based foods, are contributing to the escalated demand for animal proteins. Treatments for zoonotic diseases emerge as crucial in controlling illnesses that originate from animal proteins, understanding transmission paths, formulating effective treatments, and adopting preventive actions to lessen public health threats. For example, a report published in July 2023 by the Organization for Economic Co-operation and Development and the Food and Agriculture Organization revealed that the global meat consumption, as per a US-based agricultural commodity market, is set to augment annually at a rate of 0.1%. The growth is mainly propelled by escalating demand in middle and lower-income countries, with poultry likely to make up nearly half of the total surge in meat production by 2032. Therefore, the amplified demand for animal proteins accounts for the driving force behind the growth of the zoonotic disease treatment market.
Get Your Free Sample of the Global Zoonotic Disease Treatment Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15965&type=smp
Which Companies Are Leading the Charge in Expanding the Zoonotic Disease Treatment Market?
Major companies operating in the zoonotic disease treatment market are:
• Pfizer Inc.
• Johnson & Johnson Services Inc.
• Merck And Co. Inc.
• Bayer AG
• Sanofi S.A.
What New Trends Are Reshaping the Zoonotic Disease Treatment Market and Its Opportunities?
Leading organizations within the zoonotic disease treatment market are emphasizing on investments in the same to improve diagnostic efficiencies and enhance treatment procedures. This involves creating sophisticated diagnostic technologies like PCR kits, which enable faster detection of zoonotic pathogens and allow the implementation of specific therapeutic interventions. For instance, in October 2023, BioPerfectus, a biotechnology firm from China that specializes in diagnostic solutions, has expanded its Zoonotic Infectious Diseases Total PCR Solution by adding thirteen new members. This move is meant to strengthen its diagnostic capacities for zoonotic ailments, responsible for more than 60% of identified infectious illnesses and 75% of emerging infections. This strategic step is expected to elevate health security readiness and response, especially as climate change drives the migration of infectious diseases to new areas. Through these novel products, the company’s objective is to expedite diagnosis and improve zoonotic infection management, underlining the significance of preventive public health steps.
Get Instant Access to the Global Zoonotic Disease Treatment Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/zoonotic-disease-treatment-global-market-report
What Major Market Segments Define the Scope and Growth of the Zoonotic Disease Treatment Market?
The zoonotic disease treatment market covered in this report is segmented –
1) By Disease Type: Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Other Disease Types
2) By Drug Class: Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
3) By Causative Agent: Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
4) By Route Of Administration: Oral, Topical, Other Routes Of Administrations
5) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By Rabies: Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2) By Tuberculosis: Latent Tuberculosis Treatment, Active Tuberculosis Treatment
3) By Malaria: Plasmodium falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
4) By Leishmaniasis: Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis
5) By Ebola Virus Disease: Pre-Exposure Vaccination, Post-Exposure Treatment
6) By Other Disease Types: Zika Virus, Lassa Fever, Yellow Fever, Chikungunya
What Are the Top Regions Fueling Growth in the Zoonotic Disease Treatment Market?
North America was the largest region in the zoonotic disease treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Defining Features of the Zoonotic Disease Treatment Market?
Zoonotic disease treatment refers to the medical interventions and therapies aimed at diagnosing, managing, and preventing illnesses caused by pathogens transmitted between animals and humans. This treatment involves a combination of medication, vaccination, hygiene practices, and control measures to reduce transmission and mitigate the impact of these infections on both animal and human populations.
Browse Through More Similar Reports By The Business Research Company:
Merkel Cell Carcinoma Treatment Global Market Report 2024
Neuralgia Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report
Crohn’s Disease (CD) Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
